deltatrials

Imperial College Healthcare NHS Trust Clinical Trials

Sponsors / Imperial College Healthcare NHS Trust

According to ClinicalTrials.gov, Imperial College Healthcare NHS Trust has served as lead sponsor on 114 registered trials. Across the portfolio, 18 are in recruitment, 3 are active non-recruiting, and 49 have reached completion. 8 trials have been terminated or withdrawn. The most common reasons cited for termination include funding constraints, safety concerns. Across the portfolio, planned enrollment totals 296,705 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.

114
Total Trials
18
Recruiting
3
Other Active
49
Completed
8
Terminated / Withdrawn
296,705
Total Enrollment

Termination reasons: Other50% · Funding25% · Safety13% · Recruitment13%

Recent Terminations

  • NCT06038760 Stopped Jul 2025
    Brain Tumor
    "Lack of funding"
  • NCT03689075 Phase PHASE4 Stopped Feb 2025
    Allosensitization
    "Non-feasible due to change in clinical practice"
  • NCT03043976 Phase NA Stopped Jan 2019
    Hypertension, Pulmonary
    "Study terminated early due to ligistic reasons with study staff"
  • NCT02707770 Phase NA Stopped Dec 2017
    Chronic Obstructive Pulmonary Diseases
    "Funding for the study finished before anticipated participants enrolled"
  • NCT02999165 Stopped Nov 2017
    Breast Feeding
    "Failure to recruit participants due to change in local clinical practice."
  • NCT02841176 Phase NA Stopped Sep 2017
    Psoriatic Arthritis
    "The study was stopped due to resourcing issues."
  • NCT02872363 Phase NA Stopped Feb 2017
    Breast Cancer
    "The screening service moved to a pan-London service and the trial was not able to be continued."
  • NCT02221765 Phase PHASE1/PHASE2 Stopped May 2016
    Obesity
    "Expected PK\&no safety issues in 1B.1Cwon't proceed due to lack of 1Befficacy"

Active Trials (3 total)

Top Conditions

Top Locations